Serious Complication of Anticoagulation in Vessel Thrombosis-associated Behçet Disease

Intern Med. 2020 Jul 1;59(13):1615-1620. doi: 10.2169/internalmedicine.4109-19. Epub 2020 Mar 26.

Abstract

Anticoagulation in venous thrombosis associated with Behçet disease (BD) is controversial. We herein report a 47-year-old woman with vessel thrombosis and pulmonary artery aneurysm (PAA) associated with BD who died of massive hemoptysis under oral anticoagulant. Although she was initially diagnosed with oral contraceptive-induced venous thromboembolism, a subsequent investigation led to a diagnosis of BD. Follow-up computed tomography (CT) showed persistent thrombus, so anticoagulant was continued for persistent thrombus. She died of massive hemoptysis after the development of PAA was identified on follow-up CT during the period of anticoagulation. Great care to prevent bleeding events is required when administering anticoagulants for BD with vessel thrombosis.

Keywords: Behçet disease; anticoagulation; hemoptysis; pulmonary artery aneurysm; vessel thrombosis.

Publication types

  • Case Reports

MeSH terms

  • Aneurysm / complications*
  • Anticoagulants / adverse effects*
  • Behcet Syndrome / complications*
  • Female
  • Hemoptysis / etiology
  • Humans
  • Middle Aged
  • Pulmonary Artery / pathology
  • Thrombosis / complications*
  • Tomography, X-Ray Computed / adverse effects
  • Venous Thrombosis / complications*
  • Venous Thrombosis / drug therapy*

Substances

  • Anticoagulants